AIM ImmunoTech Inc. Common Stock (AIM)
0.4282
+0.0271 (6.76%)
NYSE· Last Trade: May 28th, 1:10 PM EDT
Detailed Quote
| Previous Close | 0.4011 |
|---|---|
| Open | 0.3411 |
| Bid | 0.4282 |
| Ask | 0.4291 |
| Day's Range | 0.3391 - 0.4887 |
| 52 Week Range | 0.2100 - 19.74 |
| Volume | 68,793,736 |
| Market Cap | 1.22M |
| PE Ratio (TTM) | 0.0231 |
| EPS (TTM) | 18.5 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 46,695,413 |
Chart
About AIM ImmunoTech Inc. Common Stock (AIM)
Aim Immunotech Inc is a biotechnology company focused on developing novel therapeutic solutions for diseases, particularly those associated with immune dysfunction, including cancer and viral infections. The company utilizes its proprietary drug development platform to advance its product candidates, with an emphasis on harnessing the immune system's potential to improve patient outcomes. Through innovative research and clinical trials, Aim Immunotech aims to bring cutting-edge treatments to market that can address unmet medical needs and enhance the quality of life for patients. Read More
News & Press Releases
Get insights into the top gainers and losers of Thursday's pre-market session.chartmill.com
Via Chartmill · May 28, 2026
Keep an eye on the top gainers and losers in Wednesday's session.chartmill.com
Via Chartmill · May 27, 2026
Most active stocks in Wednesday's sessionchartmill.com
Via Chartmill · May 27, 2026
Wednesday's session: top gainers and loserschartmill.com
Via Chartmill · May 27, 2026
Investors searching for stocks under $1 with breakout potential, AI exposure, biotech catalysts, streaming growth, and emerging healthcare innovation are increasingly focusing on a group of small-cap companies gaining momentum across multiple high-growth sectors. Companies drawing attention include Kartoon Studios (NYSE: TOON), Virax Biolabs Ltd (NASDAQ: VRAX), NextNRG Inc. (NASDAQ: NXXT), AIM ImmunoTech Inc. (NYSE: AIM), and Sunshine Biopharma Inc. (NASDAQ: SBFM).
Via AB Newswire · May 26, 2026
Curious about the stocks that are showing activity after the closing bell on Tuesday?chartmill.com
Via Chartmill · May 19, 2026
Stay updated with the stocks that are on the move in today's after-hours session.chartmill.com
Via Chartmill · May 18, 2026
These stocks are moving in today's sessionchartmill.com
Via Chartmill · May 18, 2026
Monday's session: most active stockschartmill.com
Via Chartmill · May 18, 2026
Let's have a look at the top gainers and losers in the middle of the day of today's session.chartmill.com
Via Chartmill · May 18, 2026
Which stocks are gapping on Monday?chartmill.com
Via Chartmill · May 18, 2026
These stocks that are showing activity before the opening bell on Monday.chartmill.com
Via Chartmill · May 18, 2026
Friday's session: top gainers and loserschartmill.com
Via Chartmill · May 8, 2026
Let's take a look at the stocks that are in motion in today's session.chartmill.com
Via Chartmill · May 8, 2026
Gapping stocks in Friday's sessionchartmill.com
Via Chartmill · May 8, 2026
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Via Chartmill · April 13, 2026
AIM ImmunoTech (AMEX: AIM) sees bullish momentum after final patent approval in Japan for its Ampligen-based oncology treatments.
Via Benzinga · March 20, 2026
Which stocks are moving on Wednesday?chartmill.com
Via Chartmill · March 18, 2026
Here are the top movers in Wednesday's session.chartmill.com
Via Chartmill · March 18, 2026
Let's uncover which stocks are experiencing notable gaps during today's session.chartmill.com
Via Chartmill · March 18, 2026
Discover the top movers in Wednesday's pre-market session.chartmill.com
Via Chartmill · March 18, 2026
The company said that a patent using its proprietary cancer treatment method was fully approved in Japan.
Via Stocktwits · March 18, 2026
Stay updated with the stocks that are on the move in today's pre-market session.chartmill.com
Via Chartmill · February 19, 2026
Tuesday's pre-market session: top gainers and loserschartmill.com
Via Chartmill · February 17, 2026
Here are the top movers in Thursday's session.chartmill.com
Via Chartmill · February 5, 2026